Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 293.31M P/E - EPS this Y -4.20% Ern Qtrly Grth -
Income -54.81M Forward P/E -7.39 EPS next Y 58.10% 50D Avg Chg -16.00%
Sales 13.59M PEG - EPS past 5Y - 200D Avg Chg 1.00%
Dividend N/A Price/Book 3.87 EPS next 5Y - 52W High Chg -36.00%
Recommedations 1.70 Quick Ratio 6.20 Shares Outstanding 36.05M 52W Low Chg 123.00%
Insider Own 6.59% ROA -31.67% Shares Float 18.32M Beta 0.05
Inst Own 76.47% ROE -99.97% Shares Shorted/Prior 4.78M/4.65M Price 8.20
Gross Margin 71.96% Profit Margin - Avg. Volume 451,262 Target Price 19.50
Oper. Margin -250.28% Earnings Date May 8 Volume 295,161 Change -1.32%
About scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. The company's product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity, drug-device combination product candidate consisting of a prefilled syringe containing SCP-111, preloaded into a commercially available, fixed single dose, disposable, two step mechanical autoinjector. It has a collaboration agreement with West Pharmaceutical Services, Inc. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

scPharmaceuticals Inc. News
04/24/24 scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
06:45 AM Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%
03/16/24 scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
03/13/24 scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
03/13/24 scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
03/06/24 scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
02/28/24 scPharmaceuticals to Participate in Two Upcoming Investor Conferences
02/15/24 scPharmaceuticals Inc.'s (NASDAQ:SCPH) Path To Profitability
01/04/24 scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
11/09/23 scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
11/08/23 scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
11/01/23 scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
10/19/23 Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 47%
10/05/23 scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/19/23 scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
09/05/23 scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/10/23 ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates
08/10/23 scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
08/03/23 scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023
08/01/23 scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion
SCPH Chatroom

User Image MITornado Posted - 3 days ago

$SCPH

User Image Stock_Titan Posted - 3 days ago

$SCPH scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection https://www.stocktitan.net/news/SCPH/sc-pharmaceuticals-announces-first-participant-enrolled-in-pivotal-z2f3r3z58ml2.html

User Image uscharalph Posted - 4 days ago

$SCPH Such low low volume today. That’ll change soon hopefully😎 Nice price action though. Let’s see if we can hang onto it😎

User Image mastrick Posted - 5 days ago

$SCPH Any idea when 1st quarter sales figures will be announced?

User Image uscharalph Posted - 1 week ago

$SCPH Nice close. Have a good weekend 😎

User Image unbiased77 Posted - 1 week ago

$SCPH Reading over the prospectus for the TD Cowen offering, there are several references to the fact that they "may issue and sell from time to time up to $50,000,000 of our common stock through TD Cowen as our sales agent. Sales of our common stock, if any, will be made at market prices..." The words "may" and "if any" implies that they don't necessarily mean they are not releasing all of the shares in market all at once, and can time it accordingly. It's not like the need the $50m right away, so hopefully they'll be smart enough to not have to increase the amount of shares to raise the $50m at a lower price than the $5.38 when this agreement was written up.

User Image mastrick Posted - 1 week ago

$SCPH Why is this POS dropping so much? I got in just before the approval. Looking like a bag holder at this point.

User Image MITornado Posted - 1 week ago

$SCPH So Cowen has to raise 50 million bucks on this low floater… how does that work exactly? Dilute ten million shares at $5 or 25 million shares at $2.50… or 50 million shares for a buck? What protection does JT have that this won’t be diluted to 100 millions shares?

User Image Kenzo71 Posted - 1 week ago

$SCPH the lack of Company news of any kind in between earnings announcements is having a brutal impact on the share price as traders continue to walk it down

User Image MITornado Posted - 1 week ago

$SCPH $1 cheaper than Cowen offering price

User Image unbiased77 Posted - 1 week ago

$SCPH painful to watch

User Image uscharalph Posted - 1 week ago

$SCPH I am confident that when we get 1st quarter numbers we’ll see better movement here

User Image MITornado Posted - 1 week ago

$SCPH

User Image MITornado Posted - 1 week ago

$SCPH we tapped out on inducement shares? Pretty low volume…

User Image unbiased77 Posted - 1 week ago

$SCPH guess maybe you missed this one by a few days?

User Image uscharalph Posted - 1 week ago

$SCPH Buying opportunity 😎

User Image rickinmiami Posted - 2 weeks ago

$SCPH High expectations for this one especially at current price. Can 2X in 1 to 2 months

User Image Tshanky_ Posted - 2 weeks ago

$RLYB alerted at the bottom a day before the run and it rallied. Now let’s see if $RVNC $MIST and $SCPH can do it MIST and SCPH catalysts rich Also big on $VTGN

User Image Tshanky_ Posted - 2 weeks ago

$SCPH so many catalysts

User Image JackFlaps Posted - 2 weeks ago

$SCPH It was bizarre seeing this drop after the most recent inflation news. Company has no financing needs for the foreseeable future.

User Image OldManLogan Posted - 2 weeks ago

$TGTX $ESPR $SCPH $ZVRA are competing for attention for my next incremental investment dollar... TGTX probably soonest to be bought out; ESPR likeliest to deliver largest revenue est. surprises over next few quarters; SCPH/ZVRA tops on price to 2028 EPS...

User Image Tshanky_ Posted - 2 weeks ago

$SCPH juicy catalysts coming

User Image MITornado Posted - 2 weeks ago

$SCPH friendly reminder x3

User Image MITornado Posted - 2 weeks ago

$SCPH friendly reminder X 2

User Image MITornado Posted - 2 weeks ago

$SCPH friendly reminder…

User Image Porkysabe Posted - 2 weeks ago

$SCPH Well I just rea the Ralph Mouth and MI Tornado are from San Francisco…..They love taking it up the ASS

User Image OldManLogan Posted - 2 weeks ago

$SCPH Everything that Tshanky said is why I'm building a position here as well ... HF is an enormous market and SCPH has a product that benefits everyone in the value chain; patients can stay out of hospitals, insurers save costs, even hospitals benefit... company has also beaten estimates every quarter since the product was launched... lots of upside from here.

User Image Tshanky_ Posted - 2 weeks ago

$SCPH Building a position. triple bottom play w/ beautiful upcoming catalysts. 77M cash, 59% Institutional, 35% insiders, 181M market cap, float 23M shares. Price is 5.03. Price target is 20. Upcoming catalysts: “On track to initiate a pivotal pharmacokinetic (PK) study in Q2 to support development of an 80mg/1mL auto-injector. If successful, scPharmaceuticals plans to submit a New Drug Application (NDA) to the FDA by the end of 2024.” (Data from study projected in 1H 2024) “Advanced plans to submit an sNDA to the FDA next month (April) seeking expansion of the FUROSCIX indication to include patients suffering from chronic kidney disease (CKD). Announced that the Company’s sNDA submission to the FDA seeking to expand the FUROSCIX indication to include New York Heart Association Class IV heart failure patients is currently under review by the FDA.” (Expected FDA approval August at the latest, could be as early as April)

User Image uscharalph Posted - 2 weeks ago

$SCPH Wonder when we get a glimpse at first quarter 2024 numbers?🥂

User Image MITornado Posted - 2 weeks ago

$SCPH Few thoughts… 1) ACC should give these guys a bit more exposure 2) they have posted jobs for more sales positions 3) They could easily partner with a big pharma player outside of the US for additional revenue and growth

Analyst Ratings
HC Wainwright & Co. Buy Mar 14, 24
Craig-Hallum Buy Sep 7, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Aug 2, 23
HC Wainwright & Co. Buy Jul 19, 23
HC Wainwright & Co. Buy Jun 8, 23
Maxim Group Buy May 11, 23
HC Wainwright & Co. Buy May 11, 23
HC Wainwright & Co. Buy Mar 23, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ORBIMED ADVISORS LLC 10% Owner 10% Owner Nov 25 Buy 5.25 762,380 4,002,495 5,328,328 11/29/22
5AM Partners IV, LLC 10% Owner 10% Owner Sep 06 Sell 5.14 226,622 1,164,837 503,112 09/08/22
5AM Partners IV, LLC 10% Owner 10% Owner Apr 11 Sell 5 270,000 1,350,000 537,301 04/13/22